LUMICKS
7 known investors
LUMICKS develops life science research tools that measure and apply forces around biological interactions to link structural and 'omics analysis to functional outcomes at the molecular and cellular level. Its instruments serve academic research, drug development, bioprocessing, and immuno-oncology markets.
Founders & leadership
A
AndreaCo-founder & Chief Scientific Officer
G
GerritCo-founder & Director of Product Management and Marketing
H
HugoCEO
E
EdmeeChief Financial Officer
H
HannahHR Director
Investors · 7
Lauxera Capital PartnersParis · $22M – $110M
SoftBank Vision FundLondon
European Investment BankreportedLuxembourg
Gilde Healthcarereported · 2 sourcesUtrecht · $1.1M – $55M
Irving Investorsreported · 2 sourcesNew York
Pura Vida Investmentsreported · 2 sourcesNew York
T. Rowe Pricereported · 2 sourcesBaltimore
Funding
SEC filings, press & company announcements- Undisclosed amountventure debtOct 2024Source ↗
- $93MSeries DApr 2021 · 2 sources
Farallon Capital Management (lead), Lauxera Capital Partners (lead), Gilde Healthcare, Irving Investors, Parian Global Management, Pura Vida Investments, Softbank Fund 2, Softbank Vision 2, T. Rowe Price Associates
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does LUMICKS do?
- LUMICKS develops life science research tools that measure and apply forces around biological interactions to link structural and 'omics analysis to functional outcomes at the molecular and cellular level. Its instruments serve academic research, drug development, bioprocessing, and immuno-oncology markets.
- Who founded LUMICKS?
- LUMICKS was founded by Andrea, Gerrit.
- Who are LUMICKS's investors?
- LUMICKS's investors include Lauxera Capital Partners, SoftBank Vision Fund, European Investment Bank, Gilde Healthcare, Irving Investors, Pura Vida Investments, T. Rowe Price.